Cargando…
Effectiveness of herpes zoster vaccination in an older United Kingdom population
BACKGROUND: Vaccination against herpes zoster was introduced in the United Kingdom in 2013 for individuals aged 70 years, with a phased catch-up campaign for 71–79 year olds. Vaccine introduction has resulted in a marked fall in incident herpes zoster and in post-herpetic neuralgia (PHN), but formal...
Autores principales: | Walker, Jemma L., Andrews, Nick J., Amirthalingam, Gayatri, Forbes, Harriet, Langan, Sinead M., Thomas, Sara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899761/ https://www.ncbi.nlm.nih.gov/pubmed/29555217 http://dx.doi.org/10.1016/j.vaccine.2018.02.021 |
Ejemplares similares
-
Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study
por: Langan, Sinéad M., et al.
Publicado: (2013) -
Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the United Kingdom
por: Schmidt, Sigrun A. J., et al.
Publicado: (2017) -
Quantification of risk factors for herpes zoster: population based case-control study
por: Forbes, Harriet J, et al.
Publicado: (2014) -
Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020) -
Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis
por: Grint, Daniel J, et al.
Publicado: (2020)